HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care units.

AbstractOBJECTIVE:
Diagnosing ventilator-associated pneumonia (VAP) is difficult, and misdiagnosis can lead to unnecessary and prolonged antibiotic treatment. We sought to quantify and characterize unjustified antimicrobial use for VAP and identify risk factors for continuation of antibiotics in patients without VAP after 3 days.
METHODS:
Patients suspected of having VAP were identified in 6 adult intensive care units (ICUs) over 1 year. A multidisciplinary adjudication committee determined whether the ICU team's VAP diagnosis and therapy were justified, using clinical, microbiologic, and radiographic data at diagnosis and on day 3. Outcomes included the proportion of VAP events misdiagnosed as and treated for VAP on days 1 and 3 and risk factors for the continuation of antibiotics in patients without VAP after day 3.
RESULTS:
Two hundred thirty-one events were identified as possible VAP by the ICUs. On day 1, 135 (58.4%) of them were determined to not have VAP by the committee. Antibiotics were continued for 120 (76%) of 158 events without VAP on day 3. After adjusting for acute physiology and chronic health evaluation II score and requiring vasopressors on day 1, sputum culture collection on day 3 was significantly associated with antibiotic continuation in patients without VAP. Patients without VAP or other infection received 1,183 excess days of antibiotics during the study.
CONCLUSIONS:
Overdiagnosis and treatment of VAP was common in this study and led to 1,183 excess days of antibiotics in patients with no indication for antibiotics. Clinical differences between non-VAP patients who had antibiotics continued or discontinued were minimal, suggesting that clinician preferences and behaviors contribute to unnecessary prescribing.
AuthorsVeronique Nussenblatt, Edina Avdic, Sean Berenholtz, Elizabeth Daugherty, Eric Hadhazy, Pamela A Lipsett, Lisa L Maragakis, Trish M Perl, Kathleen Speck, Sandra M Swoboda, Wendy Ziai, Sara E Cosgrove
JournalInfection control and hospital epidemiology (Infect Control Hosp Epidemiol) Vol. 35 Issue 3 Pg. 278-84 (Mar 2014) ISSN: 1559-6834 [Electronic] United States
PMID24521594 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Critical Care (statistics & numerical data)
  • Diagnostic Errors (statistics & numerical data)
  • Female
  • Humans
  • Inappropriate Prescribing (statistics & numerical data)
  • Intensive Care Units (statistics & numerical data)
  • Male
  • Middle Aged
  • Pneumonia, Ventilator-Associated (diagnosis, drug therapy)
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: